US Stock MarketDetailed Quotes
CANQF CANAQUEST MEDICAL CORPORATION
- 0.140000
- 0.0000000.00%
15min DelayClose Apr 23 16:00 ET
2.82MMarket Cap-2413P/E (TTM)
0.000000High0.000000Low0Volume0.140000Open0.140000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)20.14MShares0.43990052wk High-4.24P/B1.30MFloat Cap0.03000052wk Low--Dividend TTM9.28MShs Float0.440000Historical High--Div YieldTTM0.00%Amplitude0.030000Historical Low--Avg Price1Lot Size
CANAQUEST MEDICAL CORPORATION Key Stats
Quarterly+Annual
YOY
| (FY)Mar 31, 2018 | (Q4)Mar 31, 2018 | (Q3)Dec 31, 2017 | (Q2)Sep 30, 2017 | (Q1)Jun 30, 2017 | (FY)Mar 31, 2017 | (Q4)Mar 31, 2017 | (Q3)Dec 31, 2016 | (Q2)Sep 30, 2016 | (Q1)Jun 30, 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Operating revenue | --0 | --0 | --0 | --0 | ---- | --0 | --0 | --0 | --0 | ---- |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -43.39%1.04M | 23.95%702.45K | -61.24%172.23K | -87.83%59.13K | -69.06%103.49K | 0.85%1.83M | -45.10%566.74K | -5.46%444.33K | 139.58%485.7K | 201.71%334.5K |
| Selling and administrative expenses | -58.26%748.7K | -3.38%529.77K | -75.21%108.8K | -82.17%84.53K | -94.58%17.83K | 1.56%1.79M | -46.13%548.3K | -3.50%438.94K | 149.14%474.01K | 219.73%329.06K |
| -Selling and marketing expense | ---- | ---- | ---- | ---- | -83.02%422 | ---- | ---- | ---- | ---- | --2.49K |
| -General and administrative expense | -58.26%748.7K | -3.38%529.77K | -75.21%108.8K | -82.17%84.53K | -94.67%17.41K | 1.56%1.79M | -46.13%548.3K | -3.50%438.94K | 149.14%474.01K | 217.32%326.58K |
| Research and development costs | 3,334.36%262.01K | 10,376.57%150.23K | 5,897.38%61.77K | 755.54%35K | 7,806.98%85K | -55.35%7.63K | -62.16%1.43K | -73.13%1.03K | -31.28%4.09K | -69.35%1.08K |
| Depreciation amortization depletion | -9.85%15.71K | -9.85%3.93K | -61.85%1.66K | 42.13%6.19K | -9.85%3.93K | -13.73%17.42K | -36.70%4.36K | -1.85%4.36K | -1.89%4.36K | -1.87%4.36K |
| -Depreciation and amortization | -9.85%15.71K | -9.85%3.93K | -61.85%1.66K | 42.13%6.19K | -9.85%3.93K | -13.73%17.42K | -36.70%4.36K | -1.85%4.36K | -1.89%4.36K | -1.87%4.36K |
| Provision for doubtful accounts | ---- | ---- | --0 | ---- | ---3.27K | ---- | ---- | --0 | ---- | --0 |
| Other operating expenses | -19.18%10.22K | ---- | ---- | 4.93%3.41K | ---- | 0.66%12.65K | ---- | ---- | 56.41%3.25K | ---- |
| Operating profit | 43.39%-1.04M | -23.95%-702.45K | 61.24%-172.23K | 87.83%-59.13K | 69.06%-103.49K | -0.85%-1.83M | 45.10%-566.74K | 5.46%-444.33K | -139.58%-485.7K | -201.71%-334.5K |
| Net non-operating interest income expense | -85.42%-333.52K | -44.22%-254.27K | -1,901.02%-37.28K | -2,878.49%-110.65K | -95.12%-2.04K | -571.35%-179.87K | -3,443.82%-176.31K | 88.91%-1.86K | -16.64%-3.72K | 35.93%-1.05K |
| Non-operating interest expense | 1,763.02%85.9K | 536.10%6.66K | 1,901.02%37.28K | 5,995.57%39.93K | 95.12%2.04K | -82.79%4.61K | -78.95%1.05K | -88.91%1.86K | -79.43%655 | -35.93%1.05K |
| Total other finance cost | 41.28%247.61K | ---- | ---- | 2,211.27%70.73K | ---- | --175.26K | ---- | ---- | --3.06K | ---- |
| Other net income (expense) | 146.83%269.07K | 312.83%166.41K | 124.43%119.08K | 62.69K | -17.67%-6.94K | -630.66%-574.58K | -1.41%-78.19K | -98,962.40%-487.39K | -5.9K | |
| Gain on sale of security | 3,275.87%260.77K | -958.06%-61.99K | 9,669.03%194.63K | --57.66K | --66.1K | ---8.21K | ---5.86K | ---2.03K | ---- | ---- |
| Special income (charges) | 101.47%8.3K | 108.72%8.3K | --0 | --5.03K | -1,138.63%-73.04K | -620.22%-566.37K | -23.51%-95.23K | -95,715.45%-471.41K | --0 | ---5.9K |
| -Less:Other special charges | ---- | ---- | ---- | ---- | ---- | 775.58%548.71K | --77.57K | --471.41K | ---- | ---- |
| -Write off | -52.99%8.3K | ---- | ---- | --5.03K | ---- | --17.66K | ---- | ---- | --0 | ---- |
| Income before tax | 57.42%-1.1M | 3.76%-790.32K | 90.31%-90.43K | 78.12%-107.09K | 67.06%-112.47K | -34.59%-2.59M | 26.30%-821.23K | -91.60%-933.58K | -136.48%-489.42K | -203.51%-341.44K |
| Income tax | 0 | 0 | 0 | 0 | 0 | 17.91K | -17.91K | 0 | 0 | |
| Net income | 57.42%-1.1M | 5.82%-790.32K | 90.12%-90.43K | 78.12%-107.09K | 67.06%-112.47K | -35.09%-2.59M | 24.69%-839.14K | -87.92%-915.67K | -145.02%-489.42K | -203.51%-341.44K |
| Net income continuous Operations | 57.42%-1.1M | 5.82%-790.32K | 90.12%-90.43K | 78.12%-107.09K | 67.06%-112.47K | -35.09%-2.59M | 24.69%-839.14K | -87.92%-915.67K | -145.02%-489.42K | -203.51%-341.44K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 57.42%-1.1M | 5.82%-790.32K | 90.12%-90.43K | 78.12%-107.09K | 67.06%-112.47K | -35.09%-2.59M | 24.69%-839.14K | -87.92%-915.67K | -145.02%-489.42K | -203.51%-341.44K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 57.42%-1.1M | 5.82%-790.32K | 90.12%-90.43K | 78.12%-107.09K | 67.06%-112.47K | -35.09%-2.59M | 24.69%-839.14K | -87.92%-915.67K | -145.02%-489.42K | -203.51%-341.44K |
| Basic earnings per share | 65.22%-0.08 | 0.00%-0.06 | 88.89%-0.01 | 80.00%-0.01 | 75.00%-0.01 | -15.00%-0.23 | 45.45%-0.06 | -80.00%-0.09 | -150.00%-0.05 | -300.00%-0.04 |
| Diluted earnings per share | 65.22%-0.08 | 0.00%-0.06 | 88.89%-0.01 | 80.00%-0.01 | 75.00%-0.01 | -15.00%-0.23 | 45.45%-0.06 | -80.00%-0.09 | -150.00%-0.05 | -300.00%-0.04 |
| Dividend per share | ||||||||||
| Currency Unit | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD | CAD |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg